Loading organizations...
§ Private Profile · Boston, MA, USA
Develops radiotherapeutics for cancer treatment and imaging.
Ratio Therapeutics has raised $70.0M across 2 funding rounds.
Ratio Therapeutics has raised $70.0M in total across 2 funding rounds.
Ratio Therapeutics has raised $70.0M in total across 2 funding rounds.
Ratio Therapeutics's investors include Duquesne, Schusterman, Bristol Myers Squibb, Cornell University, Mey Boukenna , M.D., Ph.D., Duquesne Capital, Schusterman Family Investments.
Ratio Therapeutics has raised $70.0M across 2 funding rounds. Most recently, it raised $50.0M Series B in January 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 18, 2024 | $50M Series B | Duquesne, Schusterman | Bristol Myers Squibb, Cornell University, MEY Boukenna , M.d., Ph.d. | Announced |
| Feb 1, 2023 | $20M Series A | Duquesne Capital, Schusterman Family Investments | — | Announced |